Russell Investments »

Nektar Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $970k 17k 56.90
2025-06-30 $130k 5.0k 25.84

More positions owned by Russell Investments

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Broadcom Common Stock (AVGO)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Tesla Common Stock (TSLA)
Welltower Common Stock (WELL)
J P Morgan Chase And Common Stock (JPM)
Visa Common Stock (V)
Oracle Corp Common Stock (ORCL)

View all positions for Russell Investments

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics